Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cathepsin S inhibitor VBY-285 reduces chemotherapy-induced neuropathic pain in rats

Nov. 4, 2009

Humanized mAb GSK-3152314 developed for RA therapy is safe in healthy subjects

Nov. 4, 2009

Final results of two studies detail anti-arthritic activity of CP-690550

Nov. 4, 2009

Novel hybrid peptide vaccine is safe and immunogenic in phase I trial in prostate cancer

Nov. 3, 2009

ATLAS I and II data show efficacy of telavancin in cellulitis and infected ulcers

Nov. 3, 2009

Novel MEK inhibitor G-573 tested in tumor xenograft models

Nov. 3, 2009

Antisense oligonucleotides targeting huntingtin show promise for the treatment of HD

Nov. 3, 2009

LX-2931 is safe in combination with methotrexate in patients with stable RA

Nov. 3, 2009

Baminercept is safe but has no apparent efficacy in phase Ib trials in RA

Nov. 3, 2009

New data demonstrate potential of GLP-1 analogues for neurodegenerative diseases

Nov. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...